Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6245566

Title:Human embryonic germ cell line and methods of use
Inventors:Gearhart, John D.; Baltimore, MD, USA
Shamblott, Michael Joseph; Baltimore, MD, USA
Summary:Described herein are methods of producing human pluripotent embryonic germ cells via a process of culturing the human primordial germ cells in a medium containing a growth factor and a ligand that binds to a glycoprotein 130 receptor. The invention relates to primordial germ cells isolated from human embryonic tissue, such as from the gonadal ridges of a human embryo, and which are then cultured to produce cells that resemble embryonic stem cells or embryonic germ cells in morphology and pluripotency. Further disclosed are methods by which the cells may be maintained for several months in culture and can be genetically manipulated using transgenic technology to insert heterologous genetic material. Therapeutic applications in the genetic manipulation of cells and their genome are included.
Abstract:Primordial germ cells isolated from human embryonic tissue, such as from the gonadal ridges of human embryo, are disclosed. The primordial germ cells are cultured resulting in cells that resemble embryonic stem cells or embryonic germ cells in morphology and pluripotency. The cells are maintained several months in culture and can be genetically manipulated using transgenic technology to insert heterologous genetic material.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6245566
Application Number:US1998000052772
Date Filed:31/03/1998
Date Published:12/06/2001
Assignee:The Johns Hopkins University School of Medicine, Baltimore, MD, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021